Healthcare Stocks See Mixed Performance in Thursday's After-Market Session
PorAinvest
jueves, 17 de julio de 2025, 7:26 pm ET1 min de lectura
BCLI--
Telomir Pharmaceuticals' stock increased by 52.1% to $1.84, reflecting strong market sentiment towards the company. Meanwhile, Brainstorm Cell Therapeutics' stock decreased by 49.6% to $0.59, indicating a significant drop in investor confidence. VYNE Therapeutics' shares rose by 6.77% to $1.26, following positive developments in its VYN202 program for moderate-to-severe plaque psoriasis. Nurix Therapeutics' stock moved upwards by 6.45% to $12.87, while Synlogic's stock increased by 6.02% to $1.76. Salarius Pharmaceuticals' stock also saw a gain of 5.33% to $0.63 [2].
Redhill Biopharma's stock fell by 8.68% to $2.21, Sonoma Pharmaceuticals' stock declined by 7.44% to $3.31, Plus Therapeutics' stock decreased by 6.58% to $0.36, Vivani Medical's stock fell by 5.67% to $1.5, and Verrica Pharmaceuticals' stock dropped by 5.29% to $0.81 [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3TC0AI:0-australian-healthcare-stocks-gain-as-csl-advances-to-1-1-2-month-high/
[2] https://www.benzinga.com/insights/movers/25/07/46482121/12-health-care-stocks-moving-in-thursdays-after-market-session
[3] https://finance.yahoo.com/news/vyne-therapeutics-inc-vyne-gets-231802093.html
NRIX--
PSTV--
RDHL--
SLRX--
Healthcare stocks moved significantly in Thursday's after-market session. Telomir Pharmaceuticals' stock increased by 52.1% to $1.84, while Brainstorm Cell Therapeutics' stock decreased by 49.6% to $0.59. Other notable gainers include VYNE Therapeutics, Nurix Therapeutics, Synlogic, and Salarius Pharmaceuticals. Losers include Redhill Biopharma, Sonoma Pharmaceuticals, Plus Therapeutics, Vivani Medical, and Verrica Pharmaceuticals.
Healthcare stocks experienced significant movement in Thursday's after-market session. Telomir Pharmaceuticals' stock surged by 52.1% to $1.84, while Brainstorm Cell Therapeutics' stock declined by 49.6% to $0.59. Other notable gainers included VYNE Therapeutics, Nurix Therapeutics, Synlogic, and Salarius Pharmaceuticals. Conversely, Redhill Biopharma, Sonoma Pharmaceuticals, Plus Therapeutics, Vivani Medical, and Verrica Pharmaceuticals were among the losers [2].Telomir Pharmaceuticals' stock increased by 52.1% to $1.84, reflecting strong market sentiment towards the company. Meanwhile, Brainstorm Cell Therapeutics' stock decreased by 49.6% to $0.59, indicating a significant drop in investor confidence. VYNE Therapeutics' shares rose by 6.77% to $1.26, following positive developments in its VYN202 program for moderate-to-severe plaque psoriasis. Nurix Therapeutics' stock moved upwards by 6.45% to $12.87, while Synlogic's stock increased by 6.02% to $1.76. Salarius Pharmaceuticals' stock also saw a gain of 5.33% to $0.63 [2].
Redhill Biopharma's stock fell by 8.68% to $2.21, Sonoma Pharmaceuticals' stock declined by 7.44% to $3.31, Plus Therapeutics' stock decreased by 6.58% to $0.36, Vivani Medical's stock fell by 5.67% to $1.5, and Verrica Pharmaceuticals' stock dropped by 5.29% to $0.81 [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3TC0AI:0-australian-healthcare-stocks-gain-as-csl-advances-to-1-1-2-month-high/
[2] https://www.benzinga.com/insights/movers/25/07/46482121/12-health-care-stocks-moving-in-thursdays-after-market-session
[3] https://finance.yahoo.com/news/vyne-therapeutics-inc-vyne-gets-231802093.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios